CEO: John Fowler

Sector: Healthcare
Industry:Biotechnology

Exchange: Nasdaq Global Select

Country: USA

Description: Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer.


Key numbers

Market Capitalization:59328000
Shares Outstanding: 19200000
Float: 13826611
Next Earning Date:2020-03-31
TTm EPS: -1.6417
TTm Dividend Rate:
200 days moving average:7
50 days moving average: 3.1
One day percent Change: -4.33



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2016-12-31, 2017-12-31, 2018-12-31,
2016-12-31, 2017-12-31, 2018-12-31,